Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic Oncolytic Effect of HSVtk- and IL-15Rα-Armed Vaccinia Viruses Inducing Systemic Antitumor Immunity.

International journal of molecular sciences·2026
Same author

Aggregation polymorphism of photoactivatable Pt(IV) prodrugs as a strategy for the design of theranostic nanomaterials.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Humanized Murine Glioblastoma Models for Evaluation of Coxsackievirus Oncolytic Therapy.

Cancers·2026
Same author

Hybrid Fe<sub>3</sub>O<sub>4</sub>-Gd<sub>2</sub>O<sub>3</sub> Nanoparticles Prepared by High-Energy Ball Milling for Dual-Contrast Agent Applications.

International journal of molecular sciences·2026
Same author

Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma.

Current oncology (Toronto, Ont.)·2026
Same author

Plasma Protein Panel for Assessing the Risk of Alzheimer's Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.4K

Targeted Magnetic Nanoparticles for Beta-Amyloid Detection.

Nelly S Chmelyuk1,2, Aleksey A Nikitin1,2, Veronika V Vadekhina1,3

  • 1Department of Medical Nanobiotechnology, Pirogov Russian National Research Medical University, Ostrovitianov Street, 1, 117997 Moscow, Russia.

Pharmaceutics
|November 27, 2024
PubMed
Summary

Researchers developed magnetic nanoparticles (MNPs) linked to a peptide (HAEE-Cy5) for improved Alzheimer's disease imaging. This novel approach shows promise for visualizing beta-amyloid plaques using magnetic resonance imaging.

Keywords:
Alzheimer’s diseaseHAEEamyloid fibrilsmagnetic nanoparticles

More Related Videos

Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

324

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.4K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.2K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

324

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Neuroimaging

Background:

  • Alzheimer's disease pathogenesis involves beta-amyloid plaques.
  • Current magnetic resonance (MR) imaging methods for Alzheimer's lack universal acceptance.
  • Magnetic nanoparticles (MNPs) can enhance MR image contrast.

Purpose of the Study:

  • To develop and evaluate a novel MR imaging contrast agent for beta-amyloid plaques.
  • To functionalize MNPs with a peptide for targeted binding to beta-amyloid.
  • To assess the in vitro efficacy of the developed agent.

Main Methods:

  • Cubic MNPs were synthesized via thermal decomposition.
  • MNPs were covalently bonded to a fluorescently labeled tetrapeptide (HAEE-Cy5).
  • Interaction with beta-amyloid was confirmed using confocal microscopy on SH-SY5Y cells.

Main Results:

  • Synthesized MNPs demonstrated high relaxivity (approx. 200 mM⁻¹s⁻¹).
  • HAEE facilitated targeted delivery of MNPs to beta-amyloid.
  • Cy5 fluorescence confirmed effective binding and interaction in vitro.

Conclusions:

  • The HAEE-Cy5 modified MNPs show strong in vitro binding to beta-amyloid plaques.
  • This targeted nanoparticle approach holds potential for future MR imaging of Alzheimer's disease.
  • Further studies are warranted to explore in vivo applications.